论文部分内容阅读
目的:比较阿司匹林与尼莫地平在治疗偏头痛上的效果,为治疗偏头痛提供临床依据。方法:以2012年10月~2013年4月我院确诊收治的128例偏头痛患者为研究对象,根据治疗方法的不同将患者分成甲、乙两组,每组各64例。甲组用药为阿司匹林,乙组用药为尼莫地平。一个疗程(30天)后,观察比较两组疗效,并随访6个月统计两组相关并发症发病率及偏头痛复发率。结果:分析比较治疗前后两组患者康复情况,患者病情均有所缓解,甲组采用的阿司匹林的疗效更佳,总有效率高于乙组采用的尼莫地平,偏头痛的复发及并发症的发生率也是甲组低于乙组,P<0.05,差异有统计学意义。结论:阿司匹林在偏头痛的治疗中效果明显,安全性高,能有效降低复发率和相关并发症发生率。
Objective: To compare the effect of aspirin and nimodipine on the treatment of migraine, to provide a clinical basis for the treatment of migraine. Methods: A total of 128 patients with migraine admitted to our hospital from October 2012 to April 2013 were divided into two groups (64 cases in each group) according to different treatment methods. Group A medication for aspirin, Group B medication for nimodipine. After a course of treatment (30 days), the curative effect of the two groups was observed and compared. The incidence of morbidity and migraine recurrence were compared between the two groups after 6 months of follow-up. Results: The patients’ condition was relieved before and after treatment. The efficacy of aspirin in group A was better and the total effective rate was higher than that of nimodipine in group B, the recurrence of migraine and complication The incidence was also lower in group A than in group B, P <0.05, the difference was statistically significant. Conclusion: Aspirin has obvious effect in the treatment of migraine and high safety, which can effectively reduce the recurrence rate and the incidence of related complications.